Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Banco de datos
País/Región como asunto
Tipo del documento
Intervalo de año de publicación
1.
Epidemiol Infect ; 144(10): 2154-64, 2016 07.
Artículo en Inglés | MEDLINE | ID: mdl-26956947

RESUMEN

In late 2011 the New Zealand Ministry for Primary Industries reported an increase in confirmed laboratory diagnoses of salmonellosis in dairy herds. To identify risk factors for herd-level outbreaks of salmonellosis we conducted a case-control study of New Zealand dairy herds in 2011-2012. In a multivariable analysis, use of continuous feed troughs [adjusted odds ratio (aOR) 6·2, 95% confidence interval (CI) 2·0-20], use of pelletized magnesium supplements (aOR 10, 95% CI 3·3-33) and use of palm kernel meal as a supplementary feed (aOR 8·7, 95% CI 2·5-30) were positively associated with a herd-level outbreak of salmonellosis between 1 July 2011 and 31 January 2012. We conclude that supplementary feeds used on dairy farms (regardless of type) need to be stored and handled appropriately to reduce the likelihood of bacterial contamination, particularly from birds and rodents. Magnesium supplementation in the pelletized form played a role in triggering outbreaks of acute salmonellosis in New Zealand dairy herds in 2011-2012.


Asunto(s)
Enfermedades de los Bovinos/epidemiología , Brotes de Enfermedades/veterinaria , Salmonelosis Animal/epidemiología , Enfermedad Aguda , Animales , Estudios de Casos y Controles , Bovinos , Enfermedades de los Bovinos/microbiología , Industria Lechera , Nueva Zelanda/epidemiología , Salmonelosis Animal/microbiología
2.
J Biol Response Mod ; 8(4): 366-74, 1989 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-2666586

RESUMEN

New Zealand Black/New Zealand White (NZB/W) mice, a model of systemic lupus erythematosus (SLE), have age-dependent loss of interleukin-2 (IL-2) production. To determine if replacement therapy would influence the course of autoimmune disease, we injected groups of NZB/W mice with low-dose (1,500 units/day) or high-dose (15,000 units/day) purified human recombinant IL-2. Parameters of active SLE and populations of splenocytes were not altered consistently by long-term treatment with either dose of IL-2.


Asunto(s)
Interleucina-2/uso terapéutico , Lupus Eritematoso Sistémico/tratamiento farmacológico , Animales , Autoanticuerpos , Modelos Animales de Enfermedad , Relación Dosis-Respuesta a Droga , Femenino , Citometría de Flujo , Técnica del Anticuerpo Fluorescente , Glicoproteínas/sangre , Pruebas Hematológicas , Inmunoglobulinas/análisis , Interleucina-2/administración & dosificación , Lupus Eritematoso Sistémico/mortalidad , Masculino , Ratones , Proteínas Recombinantes/administración & dosificación , Proteínas Recombinantes/uso terapéutico
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA